Alpha Centric Advisors LLC Acadia Pharmaceuticals Inc Transaction History
Alpha Centric Advisors LLC
- $144 Million
- Q1 2024
A detailed history of Alpha Centric Advisors LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 45,000 shares of ACAD stock, worth $731,250. This represents 0.58% of its overall portfolio holdings.
Number of Shares
45,000
Previous 26,000
73.08%
Holding current value
$731,250
Previous $814,000
2.21%
% of portfolio
0.58%
Previous 0.64%
Shares
10 transactions
Others Institutions Holding ACAD
# of Institutions
299Shares Held
158MCall Options Held
1.88MPut Options Held
688K-
Baker Bros. Advisors LP New York, NY42.9MShares$697 Million10.04% of portfolio
-
Rtw Investments, LP New York, NY13.8MShares$225 Million4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$216 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$190 Million0.01% of portfolio
-
State Street Corp Boston, MA6MShares$97.5 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.63B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...